E
Enlivex Therapeutics Ltd D
D
ENLV
1.79000
USD
0.02
(1.13%)
مغلق
حجم التداول
29,039
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
42,691,384
الأخبار المقالات
العنوان: Enlivex Therapeutics Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.